Novartis Sues Noven Over Generic Dementia Patch
Novartis AG hit Hisamitsu Pharmaceutical Co. Inc. and subsidiary Noven Pharmaceuticals Inc. with a suit in Delaware federal court Thursday, claiming Noven's proposed generic version of the Exelon patch, used to...To view the full article, register now.
Already a subscriber? Click here to view full article